CellPharmacology & ToxicologyPeer-reviewed journal article
Mapping cellular targets of covalent cancer drugs in the entire mammalian body
Zhengyuan PangiD, Verina H. LeungiD, Cailynn C. Wang, Ahmadreza AttarpouriD, Anthony RinaldiiD, Hanbing Shen, María Dolores Moya-GarzóniD, Logan H. SiguaiD, Claire Rammel, Alexandra Selke, Christopher Glynn, Melaina Yender, Senhan XuiD, Javid J. MoslehiiD, Peng WuiD, Jonathan Z. LongiD, Maged GoubraniD, Benjamin F. CravattiD, Ye LiiD
Abstract
As our understanding of biological systems reaches single-cell and high spatial resolutions, it becomes imperative that pharmacological approaches match this precision to understand drug actions. This need is particularly urgent for the targeted covalent inhibitors that are currently re-entering the stage for cancer treatments. By leveraging the unique kinetics of click reactions, we developed volumetric clearing-assisted tissue click chemistry (vCATCH) to enable deep and homogeneous click labeling across the 3D mammalian body. With simple and passive incubation steps, vCATCH offers cellular resolution drug imaging in the entire adult mouse. We combined vCATCH with HYBRiD imaging and virtual reality to visualize and quantify in vivo targets of two clinical cancer drugs, afatinib and ibrutinib, which recapitulated their known pharmacological distribution and revealed previously unreported tissue and cell type engagement potentially linked to off-target effects. vCATCH provides a body-wide, unbiased platform to map covalent drug engagements at unprecedented scale and precision.
- organism: mouse
- assay: imaging
- research focus: drug response / drug discovery
- approach: experimental assay
- Citations
- 9
- FWCI
- 2.68
- Field percentile
- top 9%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Covalent tumor anchoring spatially orchestrates antitumor immunity
Qingke Li, Hongfei Chen, … Lei Wang·bioRxiv·May 14, 2026
- Accelerating the Validation of Endogenous On-Target Engagement and In-cellulo Kinetic Assessment for Covalent Inhibitors of KRASG12C in Early Drug Discovery
V. Kantae, R. Polanski, … B. SRINIVASAN·bioRxiv·Feb 17, 2022
- CovSite: A High-Throughput Blind Covalent Screening Framework for Reactive Site Detection
Andrew Hu, Joe Bailey, … Blaise R. Kimmel·bioRxiv·Jul 20, 2026
- SQ3370 Activates Cytotoxic Drug via Click Chemistry at Tumor and Elicits Sustained Responses in Injected & Non-injected Lesions
S. Srinivasan, N. A. Yee, … J. M. Mejia Oneto·bioRxiv·Oct 13, 2020
- Click chemistry selectively activates an auristatin protodrug with either intratumoral or systemic tumor-targeting agents
J. M. McFarland, M. Aleckovic, … J. M. M. Oneto·bioRxiv·Mar 28, 2023
- Identification of Cysteine-Reactive Early Mitotic Inhibitors
Xiaoxuan Zhang, Emma Buechler, … Jorge Z. Torres·bioRxiv·Oct 15, 2026